These knowledge gaps highlight the broader need to define the functional consequences of mt epigenetic changes– including TFAM modifications, mtDNA methylation, and non‐coding RNA activity, particularly given their emerging roles in neurodegeneration, cancer, and metabolic diseases. Here, TFAM is linked to metabolic disease.